SPHRF
Price
$0.06
Change
-$0.00 (-0.00%)
Updated
Nov 7 closing price
SXTP
Price
$1.01
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
14 days until earnings call
Ad is loading...

SPHRF vs SXTP

Header iconSPHRF vs SXTP Comparison
Open Charts SPHRF vs SXTPBanner chart's image
Starpharma Holdings
Price$0.06
Change-$0.00 (-0.00%)
Volume$1K
CapitalizationN/A
60 Degrees Pharmaceuticals
Price$1.01
Change-$0.00 (-0.00%)
Volume$29.29K
CapitalizationN/A
SPHRF vs SXTP Comparison Chart
Loading...
SXTP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
SPHRF vs. SXTP commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SPHRF is a Buy and SXTP is a Buy.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (SPHRF: $0.06 vs. SXTP: $1.01)
Brand notoriety: SPHRF and SXTP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SPHRF: 7% vs. SXTP: 33%
Market capitalization -- SPHRF: $28.66M vs. SXTP: $1.81M
SPHRF [@Biotechnology] is valued at $28.66M. SXTP’s [@Biotechnology] market capitalization is $1.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SPHRF’s FA Score shows that 1 FA rating(s) are green whileSXTP’s FA Score has 1 green FA rating(s).

  • SPHRF’s FA Score: 1 green, 4 red.
  • SXTP’s FA Score: 1 green, 4 red.
According to our system of comparison, both SPHRF and SXTP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SXTP’s TA Score shows that 5 TA indicator(s) are bullish.

  • SXTP’s TA Score: 5 bullish, 3 bearish.

Price Growth

SPHRF (@Biotechnology) experienced а -14.19% price change this week, while SXTP (@Biotechnology) price change was +11.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.86%. For the same industry, the average monthly price growth was +5.66%, and the average quarterly price growth was +6.44%.

Reported Earning Dates

SXTP is expected to report earnings on Nov 27, 2024.

Industries' Descriptions

@Biotechnology (-1.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPHRF($28.7M) has a higher market cap than SXTP($1.81M). SPHRF YTD gains are higher at: -41.956 vs. SXTP (-91.748).
SPHRFSXTPSPHRF / SXTP
Capitalization28.7M1.81M1,583%
EBITDAN/A-1.49M-
Gain YTD-41.956-91.74846%
P/E RatioN/AN/A-
RevenueN/A418K-
Total CashN/A1.58M-
Total DebtN/A157K-
FUNDAMENTALS RATINGS
SPHRF: Fundamental Ratings
SPHRF
OUTLOOK RATING
1..100
98
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SXTP
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
SXTP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QQQN31.65N/A
N/A
VictoryShares Nasdaq Next 50 ETF
SPUS43.07-0.05
-0.12%
SP Funds S&P 500 Sharia Industry Ex ETF
DFUS65.17-0.26
-0.40%
Dimensional US Equity Market ETF
NETZ75.93-1.32
-1.71%
TCW Transform Systems ETF
BKF37.90-0.88
-2.27%
iShares MSCI BIC ETF

SPHRF and

Correlation & Price change

A.I.dvisor tells us that SPHRF and CGEN have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SPHRF and CGEN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPHRF
1D Price
Change %
SPHRF100%
N/A
CGEN - SPHRF
26%
Poorly correlated
-8.33%
SPHRY - SPHRF
25%
Poorly correlated
N/A
NURPF - SPHRF
23%
Poorly correlated
N/A
SOLTF - SPHRF
23%
Poorly correlated
N/A
ASPHF - SPHRF
22%
Poorly correlated
N/A
More

SXTP and

Correlation & Price change

A.I.dvisor tells us that SXTP and RVNC have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SXTP and RVNC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SXTP
1D Price
Change %
SXTP100%
+2.02%
RVNC - SXTP
23%
Poorly correlated
+19.71%
SPHRF - SXTP
21%
Poorly correlated
N/A
OABI - SXTP
20%
Poorly correlated
-2.39%
VRAX - SXTP
20%
Poorly correlated
-11.62%
APGE - SXTP
18%
Poorly correlated
-5.14%
More